Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
Structure : Identifiant HAL de la structure : 543597
Image document

Effectiveness and safety of ustekinumab intensification at 90 Mg every four weeks In Crohn's disease: a multicenter study

Mathurin Fumery , Laurent Peyrin-Biroulet , Stéphane Nancey , Romain Altwegg , Cyrielle Gilletta , et al.
Journal of Crohn's and Colitis, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩
Article dans une revue hal-02959922v1

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

Parambir S. Dulai , Aurélien Amiot , Laurent Peyrin-Biroulet , Vipul Jairaith , Mélanie Serrero , et al.
Alimentary Pharmacology and Therapeutics, 2020, 51 (5), pp.553-564. ⟨10.1111/apt.15609⟩
Article dans une revue hal-03552288v1
Image document

Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

Nassim Hammoudi , Dominique Cazals-Hatem , Claire Auzolle , Charlotte Gardair , Marjolaine Ngollo , et al.
Clinical Gastroenterology and Hepatology, 2019, ⟨10.1016/j.cgh.2019.04.045⟩
Article dans une revue hal-02193633v1

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years

Gilles Boschetti , Stephane Nancey , Fady Daniel , Benjamin Pariente , Eric Lerebours , et al.
Inflammatory Bowel Diseases, 2016, 22 (12), pp.2924-2932. ⟨10.1097/MIB.0000000000000967⟩
Article dans une revue hal-03553388v1

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study

Mathurin Fumery , Antoine Defrance , Xavier Roblin , Romain Altwegg , Benedicte Caron , et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2022, ⟨10.1111/apt.17358⟩
Article dans une revue hal-03911091v1